Clinical Study on Xianglian Huazhuo Granules to Block ''Inflammation-Carcinoma Transformation'' of Chronic Atrophic Gastritis

Hebei Provincial Hospital of Traditional Chinese Medicine0 个研究点开始时间: 待定最近更新: 2023年2月20日

试验速览

暂无简介。

•(1) Meet the above-mentioned diagnostic criteria of Chinese and Western medicine;
•(2) Atrophic gastritis was diagnosed by electronic gastroscopy and histopathology in our hospital before enrollment;
•(3) Aged between 18 and 65 years old, no gender limit;
•(4) Subjects are informed and voluntarily sign an informed consent form.

•(1) Autoimmune gastritis (type A chronic atrophic gastritis);
•(2) Patients with gastric and duodenal ulcers, upper gastrointestinal bleeding;
•(3) Patients with severe dysplasia of gastric mucosa and suspected malignant transformation in mucosal pathology diagnosis;
•(4) Patients with serious organic diseases, such as heart (heart function NYH?-?, myocardial infarction, severe arrhythmia, etc.), brain, liver, kidney, lung and blood system and other serious primary diseases;
•(5) Those who have a history of allergies to the known drugs or ingredients in the study;
•(6) Unable to cooperate with the study if combined with severe mental illness;
•(7) Pregnant or lactating women;
•(8) Patients who are participating in other drug clinical trials or stopping the last drug research for less than one month;
•(9) Those who cannot cooperate with follow-up and investigation;
•(10) Other circumstances deemed inappropriate by the researcher.

发起方